If directly asked about all substance use, peptides would arguably fall within that scope
Freymond, D
Quick Answer Retatrutide has a half-life of approximately 6 days , according to the Phase 2 clinical trial published in the New England Journal of Medicine (Jastreboff et al., 2023)
Glucagon-like peptide-1 receptor agonists and risk of neovascular age-related macular degeneration
If you are a candidate, we outline the medication, dosing schedule, cost, and what to expect in the coming months
While individual results vary, many people begin to notice improvements in energy levels, mental clarity, and skin brightness within 2 to 4 weeks of consistent use